help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narvaez, C. J.
Right arrow Articles by Welsh, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Narvaez, C. J.
Right arrow Articles by Welsh, J.

Endocrinology, Vol 137, 400-409, Copyright © 1996 by Endocrine Society


ARTICLES

Characterization of a vitamin D3-resistant MCF-7 cell line

CJ Narvaez, K Vanweelden, I Byrne and J Welsh
W. Alton Jones Cell Science Center, Lake Placid, New York 12946, USA.

1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3], the active metabolite of vitamin D3, is a potent inhibitor of breast cancer cell growth both in vivo and in vitro. We have previously demonstrated that 1,25-(OH)2D3 induces morphology (pyknotic nuclei, chromatin and cytoplasmic condensation, and nuclear matrix protein reorganization) consistent with the activation of apoptosis in MCF-7 cells. These morphological changes in 1,25-(OH)2D3-treated cells are associated with up-regulation of TRPM-2/clusterin and cathepsin B (genes associated with mammary gland apoptosis) and down-regulation of bcl-2, an antiapoptotic gene. Thus, the inhibitory effects of 1,25-(OH)2D3 on MCF-7 cell growth involve activation of apoptosis. To investigate the mechanisms by which vitamin D3 activates apoptosis, we have selected a vitamin D3-resistant variant (MCF-7D3Res cells) by continuous culture of MCF-7 cells in 100 nM 1,25-(OH)2D3. The MCF-7D3Res cells represent a stably selected phenotype that grows equally well with or without 100 nM 1,25-(OH)2D3. In contrast to the MCF-7 cells from which they were derived (MCF-7WT cells), MCF-7D3Res cells do not exhibit apoptotic morphology, DNA fragmentation, or up-regulation of apoptosis-related proteins after treatment with 1,25-(OH)2D3. MCF-7D3Res cells exhibit cross-resistance to several vitamin D3 analogs that are potent growth regulators of MCF- 7WT cells. MCF-7WT and MCF-7D3Res cells exhibit comparable sensitivity to induction of apoptosis and up-regulation of clusterin in response to the antiestrogen 4-hydroxytamoxifen. MCF-7D3Res cells express comparable levels of the vitamin D receptor (VDR), as assessed by Western blotting or ligand binding, as MCF-7WT cells. In both sensitive and resistant cell lines, 1,25-(OH)2D3 up-regulates whereas 4- hydroxytamoxifen down-regulates VDR protein expression, indicating appropriate homologous and heterologous VDR regulation in MCF-7D3Ras cells. Gel shift analyses indicate that nuclear extracts from MCF-7WT and MCF-7D3Res cells bind equally well to the DR3 consensus vitamin D3 response element. These data suggest that MCF-7D3Res cells have a functional VDR that is uncoupled from a functional apoptotic pathway. MCF-7D3Res cells offer a unique model system for identification of the mechanisms by which vitamin D3 regulates the cell death pathway in breast cancer cells.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Macoritto, L. Nguyen-Yamamoto, D. C. Huang, S. Samuel, X. F. Yang, T. T. Wang, J. H. White, and R. Kremer
Phosphorylation of the Human Retinoid X Receptor {alpha} at Serine 260 Impairs Coactivator(s) Recruitment and Induces Hormone Resistance to Multiple Ligands
J. Biol. Chem., February 22, 2008; 283(8): 4943 - 4956.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
H.-J. Ting, B.-Y. Bao, J. E. Reeder, E. M. Messing, and Y.-F. Lee
Increased Expression of Corepressors in Aggressive Androgen-Independent Prostate Cancer Cells Results in Loss of 1{alpha},25-Dihydroxyvitamin D3 Responsiveness
Mol. Cancer Res., September 1, 2007; 5(9): 967 - 980.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
X. Peng, P. Jhaveri, E. A. Hussain-Hakimjee, and R. G. Mehta
Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1{alpha}-hydroxyvitamin D5
Carcinogenesis, May 1, 2007; 28(5): 1000 - 1007.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. M. Byrne, L. Flanagan, M. P. R. Tenniswood, and J. Welsh
Identification of a Hormone-Responsive Promoter Immediately Upstream of Exon 1c in the Human Vitamin D Receptor Gene
Endocrinology, August 1, 2000; 141(8): 2829 - 2836.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Swami, A. V. Krishnan, and D. Feldman
1{{alpha}},25-Dihydroxyvitamin D3 Down-Regulates Estrogen Receptor Abundance and Suppresses Estrogen Actions in MCF-7 Human Breast Cancer Cells
Clin. Cancer Res., August 1, 2000; 6(8): 3371 - 3379.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
I. S. Mathiasen, U. Lademann, and M. Jaattela
Apoptosis Induced by Vitamin D Compounds in Breast Cancer Cells Is Inhibited by Bcl-2 but Does Not Involve Known Caspases or p53
Cancer Res., October 1, 1999; 59(19): 4848 - 4856.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
J. X. Kang, J. Bell, R. L. Beard, and R. A. S. Chandraratna
Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Mediates the Growth-Inhibitory Effects of Retinoids
Cell Growth Differ., August 1, 1999; 10(8): 591 - 600.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
A. Agadir, G. Lazzaro, Y. Zheng, X.-K. Zhang, and R. Mehta
Resistance of HBL100 human breast epithelial cells to vitamin D action
Carcinogenesis, April 1, 1999; 20(4): 577 - 582.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. Agarwal, A. Lambert, R. A.S. Chandraratna, E. A. Rorke, and R. L. Eckert
Vitamin D Regulates Human Ectocervical Epithelial Cell Proliferation and Insulin-Like Growth Factor-Binding Protein-3 Level
Biol Reprod, March 1, 1999; 60(3): 567 - 572.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. X. Kang, J. Bell, A. Leaf, R. L. Beard, and R. A. S. Chandraratna
Retinoic acid alters the intracellular trafficking of the mannose-6-phosphate/insulin-like growth factor II receptor and lysosomal enzymes
PNAS, November 10, 1998; 95(23): 13687 - 13691.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. VanWeelden, L. Flanagan, L. Binderup, M. Tenniswood, and J. Welsh
Apoptotic Regression of MCF-7 Xenografts in Nude Mice Treated with the Vitamin D3 Analog, EB1089
Endocrinology, April 1, 1998; 139(4): 2102 - 2110.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S.-H. Zhuang and K. L. Burnstein
Antiproliferative Effect of 1{alpha},25-Dihydroxyvitamin D3 in Human Prostate Cancer Cell Line LNCaP Involves Reduction of Cyclin-Dependent Kinase 2 Activity and Persistent G1 Accumulation
Endocrinology, March 1, 1998; 139(3): 1197 - 1207.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. X. Kang, Y. Li, and A. Leaf
Mannose-6-phosphate/insulin-like growth factor-II receptor is a receptor for retinoic acid
PNAS, December 9, 1997; 94(25): 13671 - 13676.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. J. Narvaez and J. Welsh
Differential Effects of 1,25-Dihydroxyvitamin D3 and Tetradecanoylphorbol Acetate on Cell Cycle and Apoptosis of MCF-7 Cells and a Vitamin D3-Resistant Variant
Endocrinology, November 1, 1997; 138(11): 4690 - 4698.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. J. Narvaez and J. Welsh
Role of Mitochondria and Caspases in Vitamin D-mediated Apoptosis of MCF-7 Breast Cancer Cells
J. Biol. Chem., March 16, 2001; 276(12): 9101 - 9107.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society